49. CRISPR Tech and What's Missing from the Narrative
from WISterhood Hosted by Women in Science Portland
This week, Rachael and Natalie chat about the recent FDA approval of a new CRISPR gene editing technology for sickle cell disease. Tune in to hear a discussion of the patient narratives that are often overlooked in the biotech discourse, and the exorbitant costs of healthcare in the US. Email us at [email protected] and follow us @women_in_science_pdx on Instagram, Twitter, and Facebook.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of WISterhood?
This episode is 37 minutes long.
When was this WISterhood episode published?
This episode was published on January 3, 2024.
Can I download this WISterhood episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.